| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |